Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-23

Clinical Trial Update: Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether Vitamin D3 can improve cognitive function in individuals with type 2 diabetes; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Loyola University | Conditions: Diabetes, Executive Dysfunction | Phase 2 | Status: TERMINATED | Results posted: 2020-10-23